Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis

BACKGROUND: Radiofrequency ablation (RFA) can not only effectively kill hepatocellular carcinoma (HCC) tumour cells but also release tumour antigens that can provoke an immune response. However, there is no consensus regarding which antigens could constitutively be generated after RFA and could pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Shunli, Peng, Hong, Wang, Ye, Xu, Ming, Lin, Manxia, Xie, Xiaoyan, Peng, Baogang, Kuang, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793368/
https://www.ncbi.nlm.nih.gov/pubmed/29386009
http://dx.doi.org/10.1186/s12885-018-4011-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793368/
https://www.ncbi.nlm.nih.gov/pubmed/29386009
http://dx.doi.org/10.1186/s12885-018-4011-8

Ejemplares similares